OnKure Therapeutics, Inc. (OKUR) — Cash Flow Reinvestment Rate
Latest as of December 2023:
3.10x
OnKure Therapeutics, Inc. (OKUR) has a Cash Flow Reinvestment Rate of 3.10x as of December 2023, reinvesting $29.06 Million (capex $50.00K plus investments $29.01 Million) from operating cash flow of $9.38 Million. See OnKure Therapeutics, Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
3.10x
(Capex + Investments) / Operating CF
Total Reinvested
$29.06 Million
Capex + Investments
Operating Cash Flow
$9.38 Million
USD
Capital Expenditures
$50.00K
USD
Annual Cash Flow Reinvestment Rate for OnKure Therapeutics, Inc. (None–None)
Year-by-year capital reinvestment analysis for OnKure Therapeutics, Inc.. See OKUR free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow